Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

RETA Price Correlated With Financials For Reata Pharmaceuticals

Free historical financial statements for Reata Pharmaceuticals Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 22 quarters since 2017. Compare with RETA stock chart to see long term trends.

RETA Stock Compared to Quarterly

RETA Income Statement

Revenue, Net:762000
Revenue Per Share:0.0209
Selling, General & Admin Expense:25143000
Research & Development Expense:39331000
Total Operating Expenses:64747000
Operating Income:-73556000
Income Taxes:-1000
Net Income:-73555000
Earnings Per Share, Basic:-2.02
Shares Outstanding, Basic Avg:36467802

RETA Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-49122000
Net Cash from Operations Per Share:-1.347
Net Cash from Financing Activities:541000
Property, Plant & Equipment Purchases:2274000
Net Cash from Investing Activities:-336244000
Net Change in Cash & Equivalents:-384825000

RETA Balance Sheet

Cash and Cash Equivalents:147154000
Short-Term Investments:334317000
Total Current Assets:491210000
Property, Plant & Equipment, Net:11033000
Total Assets:631549000
Accounts Payable:7754000
Total Short-Term Liabilities:46325000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
2,643,082 sh
85,409 sh
3%
$86,587
$19,141
Blackrock Inc.
2,075,760 sh
-38,290 sh
-2%
$68,002
$12,254
Franklin Resources Inc
852,158 sh
-105 sh
0%
$27,917
$5,443
Ikarian Capital, LLC
Put options for 649,600 sh
649,600 sh
NEW
$21,281
$21,281
Deutsche Bank Ag\
632,758 sh
-16,896 sh
-3%
$20,729
$3,597
Sofinnova Investments, Inc.
602,545 sh
602,545 sh
NEW
$19,739
$19,739
Geode Capital Management, LLC
450,922 sh
-11,659 sh
-3%
$14,772
$2,574
FMR LLC
414,661 sh
184,021 sh
80%
$13,584
$7,502
Caption Management, LLC
Put options for 414,000 sh
414,000 sh
NEW
$13,562
$13,562
Morgan Stanley
306,401 sh
43,804 sh
17%
$10,038
$3,114
Emerald Advisers, LLC
270,846 sh
91,974 sh
51%
$8,873
$4,156
Northern Trust Corp
268,555 sh
-7,625 sh
-3%
$8,798
$1,516
Emerald Mutual Fund Advisers Trust
218,006 sh
43,690 sh
25%
$7,142
$2,545
Charles Schwab Investment Management Inc
200,153 sh
6,526 sh
3%
$6,558
$1,452
Mpm Oncology Impact Management Lp
180,000 sh
180,000 sh
NEW
$5,897
$5,897
Rubric Capital Management Lp
138,556 sh
138,556 sh
NEW
$4,539
$4,539
Bank Of New York Mellon Corp
120,675 sh
1,927 sh
2%
$3,953
$822
Ikarian Capital, LLC
86,905 sh
-13,095 sh
-13%
$2,846
$209
Verition Fund Management LLC
83,158 sh
83,158 sh
NEW
$2,724
$2,724
King Luther Capital Management Corp
68,534 sh
-9,925 sh
-13%
$2,245
$176

Data imported from Reata Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.